Drawing for BIOTRILLION

USPTO serial 97261958

BIOTRILLION

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
PEREZ, STEVEN M
Law office
TMEG LAW OFFICE 101

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with BIOTRILLION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Caroline Chicoine

Caroline Chicoine HUSCH BLACKWELL LLP190 CARONDELET PLAZASTE 600SAINT LOUIS, MO 63105

Goods and services

ClassDescriptionStatusFirst use
009downloadable computer software platforms for measuring and processing digital biomarkers to aid in the prevention, detection, or intervention of diseases, disorders, drug effects, or drug use; Downloadable computer software platforms for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects, or drug use; downloadable computer software platforms for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use and aid in digitally collecting physiological data; Downloadable computer software platforms for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects, or drug use; downloadable software for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; downloadable software for measuring and processing digital biomarkers to aid in the detection of diseases, disorders, drug effects, or drug use; downloadable software for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; downloadable software for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use and aid in digitally collecting physiologic data; downloadable software for measuring and processing digital biomarkers to aid in the detection of diseases, disorders, drug effects, or drug use; Downloadable software for use and aid in digitally collecting physiologic data of diseases, disorders, or drug effects or drug use; downloadable mobile applications for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; Downloadable mobile applications for measuring and processing digital biomarkers to aid in the detection of diseases, disorders, drug effects, or drug use; downloadable mobile applications for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects, or drug use; downloadable mobile applications for measuring and processing digital biomarkers to aid in the detection of diseases, disorders, drug effects, or drug use; downloadable mobile applications for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use and aid in digitally collecting physiologic dataACTIVEJun 5, 2024
042Software as a service (SAAS) services featuring software for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; software as a service (SAAS) services featuring software for measuring and processing digital biomarkers to aid in the prevention, detection, or intervention of diseases, disorders, drug effects, or drug use; software as a service (SAAS) services featuring software for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; software as a service (SAAS) services featuring software for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use and aid in digitally collecting physiologic data; software as a service (SAAS) services featuring downloadable software for use and aid in digitally collecting physiologic data of diseases, disorders, drug effects or drug useACTIVEJun 5, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
May 27, 2025MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 27, 2025ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 2, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 2, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 2, 2025CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 15, 2025SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 15, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 29, 2024IUAFUSE AMENDMENT FILED—
Oct 29, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 16, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 15, 2024EX1GSOU EXTENSION 1 GRANTED—
Apr 15, 2024EXT1SOU EXTENSION 1 FILED—
Apr 15, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 31, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 5, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 5, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 16, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 29, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 4, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 3, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 3, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 6, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 6, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 6, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 6, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 6, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 6, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 5, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 5, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 5, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 23, 2022DOCKASSIGNED TO EXAMINER—
Feb 15, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 14, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance